Victoza (liraglutide) 6 mg/ml is a GLP-1 receptor agonist used to improve blood sugar con
Victoza (liraglutide) 6 mg/ml is a GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. It is administered as a once-daily subcutaneous injection. Victoza helps lower blood glucose levels by increasing insulin secretion, slowing gastric emptying, and reducing glucagon release, thereby improving glycemic control and potentially aiding in weight loss.
Related products